First Report on Successful Conversion of Long-Term Treatment of Recurrent Atypical Hemolytic Uremic Syndrome With Eculizumab to Ravulizumab in a Renal Transplant Patient

Overview of attention for article published in Transplant International, October 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

twitter: 2 X users

facebook: 2 Facebook pages

Citations

dimensions_citation: 6 Dimensions

Readers on

mendeley: 8 Mendeley

Summary X Facebook Dimensions citations

So far, Altmetric has seen 2 public wall posts from 2 users.

aHUS Canada, 27 Oct 2022

The new PMC design is here! Learn more about navigating our updated article layout. The PMC legacy view will also be available…

aHUS Alliance, 27 Oct 2022

Of special interest for aHUS patients with kidney transplants (or those considering this) https://www.ncbi.nlm.nih.gov/pmc/articl…

This page shows the most recent Facebook posts that mention this research output.

Click here to find out how to access more activity.